Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viscosupplementation plus triamcinolone for knee osteoarthritis quality of life
RBR-2mxrcjwPhase 4Completed
- Sponsor
- Uningá
- Start
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium hyaluronate and triamcinolone hexacetonide in knee osteoarthritis (OA), sponsored by Uningá. Started Jan 2024; status: completed.
02
Drugs
sodium hyaluronatetriamcinolone hexacetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-2mxrcjw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2mxrcjw.